Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker ... It plans to submit orforglipron for FDA approval for obesity in Q4, and for type 2 diabetes in the first half of 2026.

It plans to submit orforglipron for FDA approval for obesity in Q4, and for type 2 diabetes ... On the day of Eli Lilly's earnings report, CVS Health announced that its pharmacy benefit manager ...

Alexandria is a contrarian Buy opportunity with a 7.5% yield, robust fundamentals, & growth potential. See why ARE is Ideal ...

Healthcare has been a tough sector in 2025. It looks like Q2 could be the low point for healthcare earnings growth for this ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... number of billionaire investors, updated as of Q4 2024. All of these billionaire investors are founders ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... with the highest number of hedge fund holders as of Q4 2024. We sourced the hedge fund sentiment data from ...

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound copycats is enforced this month, its CEO said on Wednesday after the ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best income stocks. Amid concerns over trade restrictions and a weakening economy ...